20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Infarction, Middle Cerebral Artery in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ćosić, A; Drenjančević, I; Mihalj, M; Mišir, M; Novak, S; Renić, M; Vesel, M | 1 |
| Dunn, KM; Falck, J; Flasch, AK; Harder, DR; Renic, M; Roman, RJ | 1 |
| Harder, DR; Kawashima, N; Klaus, JA; Koehler, RC; Miyata, N; Omura, T; Onishi, M; Renic, M; Roman, RJ | 1 |
| Eto, K; Marumo, T; Nabekura, J; Omura, T; Wake, H | 1 |
| Bandou, K; Cambj-Sapunar, L; Doi, M; Harder, DR; Kametani, S; Miyata, N; Okuyama, S; Omura, T; Roman, RJ; Sato, M; Seki, T; Tanaka, Y; Taniguchi, K | 1 |
5 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats.
Topics: Amidines; Animals; Aryl Hydrocarbon Hydroxylases; Brain; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Cytochrome P450 Family 4; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Epoxide Hydrolases; Female; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Hyperbaric Oxygenation; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Nitric Oxide Synthase Type III; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Steroid 16-alpha-Hydroxylase; Time Factors | 2017 |
Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
Topics: Amidines; Animals; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Cytochrome P-450 CYP4A; Disease Models, Animal; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension; Infarction, Middle Cerebral Artery; Isoenzymes; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Severity of Illness Index; Stroke; Time Factors; Up-Regulation | 2008 |
Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion.
Topics: Animals; Brain; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Disease Models, Animal; Formamides; Hydroxyeicosatetraenoic Acids; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mass Spectrometry; Morpholines; Neuroprotective Agents; Rats; Rats, Wistar | 2009 |
The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice.
Topics: Animals; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Formamides; Homeostasis; Hydroxyeicosatetraenoic Acids; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Microcirculation; Morpholines | 2010 |
Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
Topics: Animals; Brain; Carotid Arteries; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Circulation; Collagenases; Cytochrome P-450 CYP4A; Formamides; Hydroxyeicosatetraenoic Acids; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Isoenzymes; Male; Morpholines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Stroke | 2005 |